logo

Genomic Evolution of Breast Cancer Metastasis

   

Added on  2022-08-18

4 Pages791 Words17 Views
 | 
 | 
 | 
Running head: REPORT 0
BREAST CANCER
FEBRUARY 13, 2020
STUDENT DETAILS:
Genomic Evolution of Breast Cancer Metastasis_1

REPORT 1
Answer 1:
M.D. is a woman of 50 years. M.D. has been diagnosed with lobulated mass in the left
breast. M.D. suffered stereotactic needle biopsy. The stereotactic needle biopsy included
restraining breast to determine specific location of tumour by conducting x ray analysis.
Afterwards, it inserted special biopsy needle to extract tumour cell. After getting specimen, the
pathologist measured it. Further, the pathologist created opinion (Yates, et. al, 2017).
Answer 2:
As per the TNM staging system, her classification would include stage ii. The stage ii
includes lymph nodes along with primary tumour. It is considered as invasive breast cancer. At
this level, the tumour assesses between two centimetre to five centimetre. The cancer has spread
to lymph nodes in arm as the breast cancer. Moreover, the stage II of breast cancer states the
slightly more innovative or forward-looking way of the disease (DeSantis, et. al, 2017).
Answer 3:
The initial treatment for the breast cancer is surgical intervention. M.D. had Modified
Radical Mastectomy. The modified radical mastectomy is considered as process where whole
breast is removed including nipple, skin, as well as axillary lymph nodes. However, the
pectoralis main muscle is freed. In general, the modified radical mastectomy was an initial way
to treat breast cancer. It can see that the whole breast as well as lymph nodes are detached in the
procedure of Modified Radical Mastectomy (Finn, et. al, 2016).
Answer 4:
Genomic Evolution of Breast Cancer Metastasis_2

End of preview

Want to access all the pages? Upload your documents or become a member.

Related Documents
(PDF) An Overview of Cancer Treatment Modalities
|9
|2031
|122